António Bernadino Guimaraes Parada
Fortune : 321 690 $ au 30/06/2026
Fortune : 321 690 $ au 30/06/2026
António Bernadino Guimaraes Parada was the founder of Biocodex Incubação de Empresas de Ciências da Vida SA, founded in 2002, where the title held was Chief Executive Officer from 2002 to 2008.
Mr. Guimaraes Parada is the founder of Fairjourney Biologics SA, founded in 2012, holding the title Member-Supervisory Board starting in 2025.
The current job is Independent Director at iBio, Inc., starting in 2024.
Former jobs include Chief Executive Officer at IONTAS Ltd. (United Kingdom); Site Manager at Ablynx NV from 2008 to 2012; Manager-Clinical Trial Unit at Instituto Português de Oncologia do Porto FG, EPE from 2011 to 2012; and General Manager at Instituto de Biologia Molecular e Celular from 2002 to 2013.
Education includes undergraduate studies at the University of Porto and an MBA from Portuguese Catholic University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IBIO, INC. 0,53% | 20/11/2025 | 183 823 ( 0,53% ) | 321 690 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 25/11/2024 |
Fairjourney Biologics SA
Fairjourney Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company that develops antibody treatments | Fondateur | 01/05/2012 |
| Sociétés | Poste | Fin |
|---|---|---|
Instituto de Biologia Molecular e Celular | Corporate Officer/Principal | 01/01/2013 |
Instituto Português de Oncologia do Porto FG, EPE
Instituto Português de Oncologia do Porto FG, EPE Hospital/Nursing ManagementHealth Services Provides oncological treatment, research, teaching, pharmacy and online portal for consultation services | Corporate Officer/Principal | 01/05/2012 |
| ABLYNX | Corporate Officer/Principal | 01/03/2012 |
Biocodex Incubação de Empresas de Ciências da Vida SA
Biocodex Incubação de Empresas de Ciências da Vida SA BiotechnologyHealth Technology Invests in and develops biotechnology research businesses and programs | Directeur Général | 01/12/2008 |
IONTAS Ltd. (United Kingdom)
IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Provides antibody discovery services | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
University of Porto
University of Porto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Portuguese Catholic University
Portuguese Catholic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iBio, Inc.
iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
Biocodex Incubação de Empresas de Ciências da Vida SA
Biocodex Incubação de Empresas de Ciências da Vida SA BiotechnologyHealth Technology Invests in and develops biotechnology research businesses and programs | Health Technology |
Instituto Português de Oncologia do Porto FG, EPE
Instituto Português de Oncologia do Porto FG, EPE Hospital/Nursing ManagementHealth Services Provides oncological treatment, research, teaching, pharmacy and online portal for consultation services | Health Services |
Instituto de Biologia Molecular e Celular | |
Fairjourney Biologics SA
Fairjourney Biologics SA BiotechnologyHealth Technology Operates as a biotechnology company that develops antibody treatments | Health Technology |
IONTAS Ltd. (United Kingdom)
IONTAS Ltd. (United Kingdom) BiotechnologyHealth Technology Provides antibody discovery services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national